NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP)
CUSIP: 44975P103
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
- Shares outstanding
- 265,214,861
- Total 13F shares
- 38,195,150
- Share change
- -2,107,696
- Total reported value
- $430,214,056
- Put/Call ratio
- 160%
- Price per share
- $11.30
- Number of holders
- 91
- Value change
- -$43,072,457
- Number of buys
- 43
- Number of sells
- 69
Quarterly Holders Quick Answers
What is CUSIP 44975P103?
CUSIP 44975P103 identifies NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 44975P103:
Top shareholders of NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| HHLR ADVISORS, LTD. |
13F
|
Company |
2.7%
|
7,182,850
|
$116,649,000 | — | 31 Mar 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2%
|
5,395,157
|
$87,617,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.3%
|
3,403,271
|
$55,270,000 | — | 31 Mar 2022 | |
| Cederberg Capital Ltd |
13F
|
Company |
0.84%
|
2,215,385
|
$35,978,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.61%
|
1,624,408
|
$26,381,000 | — | 31 Mar 2022 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
0.54%
|
1,420,225
|
$23,064,000 | — | 31 Mar 2022 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.53%
|
1,400,000
|
$22,736,000 | — | 31 Mar 2022 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.4%
|
1,049,691
|
$17,047,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.38%
|
1,004,609
|
$16,315,000 | — | 31 Mar 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.33%
|
875,213
|
$14,213,000 | — | 31 Mar 2022 | |
| Artal Group S.A. |
13F
|
Company |
0.32%
|
850,000
|
$13,804,000 | — | 31 Mar 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.28%
|
751,254
|
$12,200,000 | — | 31 Mar 2022 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.28%
|
747,127
|
$12,133,000 | — | 31 Mar 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.27%
|
726,692
|
$11,801,000 | — | 31 Mar 2022 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
0.26%
|
678,600
|
$11,020,000 | — | 31 Mar 2022 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.23%
|
617,000
|
$10,020,000 | — | 31 Mar 2022 | |
| IvyRock Asset Management (HK) Ltd |
13F
|
Company |
0.23%
|
613,356
|
$9,961,000 | — | 31 Mar 2022 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
0.21%
|
566,650
|
$9,202,396 | — | 31 Mar 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.2%
|
535,596
|
$8,698,000 | — | 31 Mar 2022 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.18%
|
479,503
|
$7,787,129 | — | 31 Mar 2022 | |
| E Fund Management Co., Ltd. |
13F
|
Company |
0.16%
|
434,823
|
$7,011,000 | — | 31 Mar 2022 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.13%
|
338,919
|
$5,504,000 | — | 31 Mar 2022 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
0.12%
|
328,376
|
$5,333,000 | — | 31 Mar 2022 | |
| Bridgewater Associates, LP |
13F
|
Company |
0.12%
|
311,998
|
$5,067,000 | — | 31 Mar 2022 | |
| Banco Santander, S.A. |
13F
|
Company |
0.11%
|
300,000
|
$4,872,000 | — | 31 Mar 2022 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.11%
|
289,022
|
$4,694,000 | — | 31 Mar 2022 | |
| NORGES BANK |
13F
|
Company |
0.1%
|
269,330
|
$4,373,919 | — | 31 Mar 2022 | |
| INDUS CAPITAL PARTNERS, LLC |
13F
|
Company |
0.1%
|
262,685
|
$4,266,000 | — | 31 Mar 2022 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.1%
|
255,589
|
$4,151,000 | — | 31 Mar 2022 | |
| Legal & General Group Plc |
13F
|
Company |
0.09%
|
248,687
|
$4,039,000 | — | 31 Mar 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0.09%
|
240,881
|
$3,912,000 | — | 31 Mar 2022 | |
| Handelsbanken Fonder AB |
13F
|
Company |
0.09%
|
225,502
|
$3,662,000 | — | 31 Mar 2022 | |
| EDBI Pte Ltd |
13F
|
Company |
0.08%
|
222,136
|
$3,607,000 | — | 31 Mar 2022 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.08%
|
203,830
|
$3,310,199 | — | 31 Mar 2022 | |
| Zeal Asset Management Ltd |
13F
|
Company |
0.07%
|
194,538
|
$3,248,000 | — | 31 Mar 2022 | |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP |
13F
|
Company |
0.07%
|
196,349
|
$3,189,000 | — | 31 Mar 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.07%
|
181,353
|
$2,945,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.07%
|
181,314
|
$2,926,000 | — | 31 Mar 2022 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.06%
|
169,320
|
$2,749,000 | — | 31 Mar 2022 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.06%
|
162,580
|
$2,640,000 | — | 31 Mar 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.06%
|
153,400
|
$2,491,000 | — | 31 Mar 2022 | |
| TOBAM |
13F
|
Company |
0.06%
|
150,200
|
$2,439,000 | — | 31 Mar 2022 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.01%
|
18,000
|
$2,377,000 | — | 31 Mar 2022 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.05%
|
137,110
|
$2,241,000 | — | 31 Mar 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.05%
|
137,400
|
$2,231,000 | — | 31 Mar 2022 | |
| CAPITAL FUND MANAGEMENT S.A. |
13F
|
Company |
0.05%
|
128,847
|
$2,092,475 | — | 31 Mar 2022 | |
| Old Well Partners, LLC |
13F
|
Company |
0.05%
|
126,525
|
$2,055,000 | — | 31 Mar 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.04%
|
116,137
|
$1,886,000 | — | 31 Mar 2022 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.04%
|
111,120
|
$1,805,000 | — | 31 Mar 2022 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.04%
|
106,143
|
$1,724,000 | — | 31 Mar 2022 |
Institutional Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q2 2022
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.